Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology Reports|August 17, 2021
Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcomaJonathan T Hunt, Laura M Chambers, Meng Yao, et al.
American Journal of Obstetrics and Gynecology|May 18, 2020
Use of prophylactic closed incision negative pressure therapy is associated with reduced surgical site infections in gynecologic oncology patients undergoing laparotomyLaura Moulton Chambers, Molly Morton, Erika Lampert, et al.
Technology in Cancer Research & Treatment|September 17, 2009
Stereotactic body radiosurgery for pelvic relapse of gynecologic malignanciesCharles Kunos, William Chen, Robert DeBernardo, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2012
Hematological toxicity after robotic stereotactic body radiosurgery for treatment of metastatic gynecologic malignanciesCharles A Kunos, Robert Debernardo, Tomas Radivoyevitch, et al.
Future Oncology (London, England)|February 5, 2014
Acute gastrointestinal toxicity after robotic stereotactic ablative radiotherapy for treatment of metastatic gynecological malignanciesMazen Mislmani, Heidi Frasure, Somu Suppiah, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 12, 2015
Postoperative Complications After Distal Pancreatectomy Performed During Cytoreductive Surgery for Gynecologic MalignanciesHaider Mahdi, Peter G Rose, Samantha Gonzalez, et al.
Frontiers in Oncology|December 11, 2012
Phase II Clinical Trial of Robotic Stereotactic Body Radiosurgery for Metastatic Gynecologic MalignanciesCharles A Kunos, James Brindle, Steven Waggoner, et al.
Journal of Nuclear Medicine & Radiation Therapy|December 16, 2014
<sup>18</sup>FDG-PET/CT Definition of Clinical Target Volume for Robotic Stereotactic Body Radiosurgery Treatment of Metastatic Gynecologic MalignanciesCharles A Kunos, Robert Debernardo, Jeffrey Fabien, et al.
Surgery|May 14, 2023
The quality and content of hyperthermic intraperitoneal chemotherapy information available to patients: An evaluation of North American hyperthermic intraperitoneal chemotherapy websitesSarah L Remer, Tara M Connelly, Cillian Clancy, et al.
Gynecologic Oncology|July 26, 2018
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group studyRobert A Burger, Wei Deng, Vicky Makker, et al.
Pageof 7